nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—KDR—malaria	0.387	1	CbGaD
Regorafenib—CYP2B6—Artemether—malaria	0.0306	0.0801	CbGbCtD
Regorafenib—CYP2C8—Sulfadiazine—malaria	0.0273	0.0714	CbGbCtD
Regorafenib—CYP2C8—Pyrimethamine—malaria	0.0273	0.0714	CbGbCtD
Regorafenib—CYP2C19—Artemether—malaria	0.0195	0.0509	CbGbCtD
Regorafenib—CYP3A4—Clindamycin—malaria	0.0193	0.0504	CbGbCtD
Regorafenib—CYP2C9—Pyrimethamine—malaria	0.019	0.0498	CbGbCtD
Regorafenib—CYP2C9—Sulfadiazine—malaria	0.019	0.0498	CbGbCtD
Regorafenib—CYP2C19—Proguanil—malaria	0.0183	0.0479	CbGbCtD
Regorafenib—CYP2B6—Quinidine—malaria	0.0163	0.0427	CbGbCtD
Regorafenib—CYP2C9—Artemether—malaria	0.0162	0.0423	CbGbCtD
Regorafenib—CYP2C9—Proguanil—malaria	0.0152	0.0398	CbGbCtD
Regorafenib—CYP2C8—Quinine—malaria	0.0141	0.0368	CbGbCtD
Regorafenib—CYP2C8—Quinidine—malaria	0.0124	0.0323	CbGbCtD
Regorafenib—CYP2C19—Quinine—malaria	0.0118	0.0309	CbGbCtD
Regorafenib—CYP3A4—Sulfadiazine—malaria	0.0111	0.029	CbGbCtD
Regorafenib—CYP2C8—Dapsone—malaria	0.0107	0.0279	CbGbCtD
Regorafenib—CYP2C9—Quinine—malaria	0.0098	0.0257	CbGbCtD
Regorafenib—ABCB1—Quinine—malaria	0.00951	0.0249	CbGbCtD
Regorafenib—CYP3A4—Artemether—malaria	0.00941	0.0246	CbGbCtD
Regorafenib—CYP2C19—Dapsone—malaria	0.00894	0.0234	CbGbCtD
Regorafenib—CYP3A4—Proguanil—malaria	0.00885	0.0231	CbGbCtD
Regorafenib—CYP2C9—Quinidine—malaria	0.00862	0.0225	CbGbCtD
Regorafenib—CYP3A4—Doxycycline—malaria	0.00839	0.0219	CbGbCtD
Regorafenib—ABCB1—Quinidine—malaria	0.00836	0.0219	CbGbCtD
Regorafenib—CYP2C9—Dapsone—malaria	0.00743	0.0194	CbGbCtD
Regorafenib—CYP3A4—Quinine—malaria	0.0057	0.0149	CbGbCtD
Regorafenib—CYP3A4—Quinidine—malaria	0.00501	0.0131	CbGbCtD
Regorafenib—CYP3A4—Dapsone—malaria	0.00432	0.0113	CbGbCtD
Regorafenib—Amylase increased—Proguanil—malaria	0.0037	0.047	CcSEcCtD
Regorafenib—Sorafenib—KDR—malaria	0.00252	1	CrCbGaD
Regorafenib—FLT4—endothelium—malaria	0.00199	0.025	CbGeAlD
Regorafenib—FRK—hematopoietic system—malaria	0.00178	0.0224	CbGeAlD
Regorafenib—DDR2—hematopoietic system—malaria	0.0016	0.0201	CbGeAlD
Regorafenib—TEK—endothelium—malaria	0.0016	0.0201	CbGeAlD
Regorafenib—FLT1—endothelium—malaria	0.00154	0.0194	CbGeAlD
Regorafenib—Toxic epidermal necrolysis—Pyrimethamine—malaria	0.00148	0.0188	CcSEcCtD
Regorafenib—FLT1—blood plasma—malaria	0.00137	0.0172	CbGeAlD
Regorafenib—KDR—endothelium—malaria	0.0013	0.0164	CbGeAlD
Regorafenib—Stevens-Johnson syndrome—Pyrimethamine—malaria	0.00125	0.0159	CcSEcCtD
Regorafenib—UGT1A1—blood plasma—malaria	0.00123	0.0154	CbGeAlD
Regorafenib—KDR—blood plasma—malaria	0.00116	0.0146	CbGeAlD
Regorafenib—KIT—endothelium—malaria	0.00116	0.0145	CbGeAlD
Regorafenib—DDR2—digestive system—malaria	0.00111	0.014	CbGeAlD
Regorafenib—Hepatotoxicity—Quinidine—malaria	0.00111	0.014	CcSEcCtD
Regorafenib—Hepatotoxicity—Quinine—malaria	0.00111	0.014	CcSEcCtD
Regorafenib—Erythema multiforme—Pyrimethamine—malaria	0.00107	0.0136	CcSEcCtD
Regorafenib—KIT—blood plasma—malaria	0.00103	0.0129	CbGeAlD
Regorafenib—Proteinuria—Dapsone—malaria	0.00102	0.013	CcSEcCtD
Regorafenib—Protein urine present—Dapsone—malaria	0.00101	0.0128	CcSEcCtD
Regorafenib—Hepatotoxicity—Quinidine barbiturate—malaria	0.000999	0.0127	CcSEcCtD
Regorafenib—Proteinuria—Clindamycin—malaria	0.000991	0.0126	CcSEcCtD
Regorafenib—Protein urine present—Clindamycin—malaria	0.000978	0.0124	CcSEcCtD
Regorafenib—FLT4—hematopoietic system—malaria	0.000975	0.0123	CbGeAlD
Regorafenib—Stomatitis—Proguanil—malaria	0.000961	0.0122	CcSEcCtD
Regorafenib—Hepatobiliary disease—Proguanil—malaria	0.000932	0.0118	CcSEcCtD
Regorafenib—FRK—liver—malaria	0.000924	0.0116	CbGeAlD
Regorafenib—Liver injury—Quinidine barbiturate—malaria	0.000917	0.0116	CcSEcCtD
Regorafenib—Leukopenia—Pyrimethamine—malaria	0.000885	0.0112	CcSEcCtD
Regorafenib—RET—hematopoietic system—malaria	0.000861	0.0108	CbGeAlD
Regorafenib—FGFR2—saliva-secreting gland—malaria	0.000857	0.0108	CbGeAlD
Regorafenib—Hypocalcaemia—Quinidine barbiturate—malaria	0.000842	0.0107	CcSEcCtD
Regorafenib—EPHA2—saliva-secreting gland—malaria	0.000842	0.0106	CbGeAlD
Regorafenib—DDR2—liver—malaria	0.000829	0.0104	CbGeAlD
Regorafenib—FGFR2—hematopoietic system—malaria	0.000818	0.0103	CbGeAlD
Regorafenib—UGT1A9—kidney—malaria	0.00081	0.0102	CbGeAlD
Regorafenib—EPHA2—hematopoietic system—malaria	0.000804	0.0101	CbGeAlD
Regorafenib—Mediastinal disorder—Proguanil—malaria	0.000798	0.0101	CcSEcCtD
Regorafenib—FLT1—saliva-secreting gland—malaria	0.000794	0.00999	CbGeAlD
Regorafenib—Thrombocytopenia—Pyrimethamine—malaria	0.00079	0.01	CcSEcCtD
Regorafenib—RAF1—saliva-secreting gland—malaria	0.00079	0.00993	CbGeAlD
Regorafenib—TEK—hematopoietic system—malaria	0.000784	0.00986	CbGeAlD
Regorafenib—Malnutrition—Proguanil—malaria	0.00077	0.00978	CcSEcCtD
Regorafenib—Toxic epidermal necrolysis—Sulfadiazine—malaria	0.000765	0.0097	CcSEcCtD
Regorafenib—FLT1—hematopoietic system—malaria	0.000758	0.00953	CbGeAlD
Regorafenib—RAF1—hematopoietic system—malaria	0.000754	0.00948	CbGeAlD
Regorafenib—BRAF—blood—malaria	0.000749	0.00942	CbGeAlD
Regorafenib—BRAF—bone marrow—malaria	0.000725	0.00912	CbGeAlD
Regorafenib—EPHX2—blood—malaria	0.000716	0.00901	CbGeAlD
Regorafenib—PDGFRA—hematopoietic system—malaria	0.00071	0.00893	CbGeAlD
Regorafenib—RET—kidney—malaria	0.000706	0.00887	CbGeAlD
Regorafenib—Decreased appetite—Pyrimethamine—malaria	0.000702	0.0089	CcSEcCtD
Regorafenib—UGT1A9—digestive system—malaria	0.000688	0.00865	CbGeAlD
Regorafenib—UGT1A1—hematopoietic system—malaria	0.000678	0.00852	CbGeAlD
Regorafenib—KDR—saliva-secreting gland—malaria	0.000672	0.00844	CbGeAlD
Regorafenib—FGFR2—kidney—malaria	0.00067	0.00843	CbGeAlD
Regorafenib—CYP2C19—blood plasma—malaria	0.000664	0.00835	CbGeAlD
Regorafenib—DDR2—brain—malaria	0.000658	0.00827	CbGeAlD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.000651	0.00827	CcSEcCtD
Regorafenib—Stevens-Johnson syndrome—Sulfadiazine—malaria	0.000649	0.00823	CcSEcCtD
Regorafenib—FLT4—blood—malaria	0.000646	0.00812	CbGeAlD
Regorafenib—TEK—kidney—malaria	0.000643	0.00808	CbGeAlD
Regorafenib—KDR—hematopoietic system—malaria	0.000641	0.00806	CbGeAlD
Regorafenib—Stomatitis—Sulfadiazine—malaria	0.000638	0.00809	CcSEcCtD
Regorafenib—FLT4—bone marrow—malaria	0.000625	0.00786	CbGeAlD
Regorafenib—MAPK11—brain—malaria	0.000624	0.00784	CbGeAlD
Regorafenib—FLT1—kidney—malaria	0.000621	0.00781	CbGeAlD
Regorafenib—RAF1—kidney—malaria	0.000618	0.00777	CbGeAlD
Regorafenib—Nervous system disorder—Proguanil—malaria	0.000617	0.00782	CcSEcCtD
Regorafenib—Skin disorder—Proguanil—malaria	0.000611	0.00775	CcSEcCtD
Regorafenib—RET—digestive system—malaria	0.000599	0.00753	CbGeAlD
Regorafenib—KIT—saliva-secreting gland—malaria	0.000595	0.00748	CbGeAlD
Regorafenib—BRAF—liver—malaria	0.000586	0.00737	CbGeAlD
Regorafenib—PDGFRB—saliva-secreting gland—malaria	0.000581	0.00731	CbGeAlD
Regorafenib—CYP2C8—blood plasma—malaria	0.00058	0.00729	CbGeAlD
Regorafenib—Dry skin—Clindamycin—malaria	0.00058	0.00735	CcSEcCtD
Regorafenib—RET—blood—malaria	0.00057	0.00717	CbGeAlD
Regorafenib—Toxic epidermal necrolysis—Clindamycin—malaria	0.000569	0.00723	CcSEcCtD
Regorafenib—FGFR2—digestive system—malaria	0.000569	0.00715	CbGeAlD
Regorafenib—KIT—hematopoietic system—malaria	0.000568	0.00714	CbGeAlD
Regorafenib—EPHX2—liver—malaria	0.00056	0.00704	CbGeAlD
Regorafenib—EPHA2—digestive system—malaria	0.000559	0.00703	CbGeAlD
Regorafenib—Toxic epidermal necrolysis—Quinidine—malaria	0.000559	0.00709	CcSEcCtD
Regorafenib—Toxic epidermal necrolysis—Quinine—malaria	0.000559	0.00709	CcSEcCtD
Regorafenib—UGT1A1—kidney—malaria	0.000555	0.00698	CbGeAlD
Regorafenib—Erythema multiforme—Sulfadiazine—malaria	0.000555	0.00705	CcSEcCtD
Regorafenib—PDGFRB—hematopoietic system—malaria	0.000555	0.00697	CbGeAlD
Regorafenib—Decreased appetite—Proguanil—malaria	0.000547	0.00694	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Proguanil—malaria	0.000543	0.00689	CcSEcCtD
Regorafenib—FGFR2—blood—malaria	0.000542	0.00681	CbGeAlD
Regorafenib—EPHA2—blood—malaria	0.000532	0.0067	CbGeAlD
Regorafenib—FLT1—digestive system—malaria	0.000527	0.00663	CbGeAlD
Regorafenib—KDR—kidney—malaria	0.000525	0.00661	CbGeAlD
Regorafenib—RAF1—digestive system—malaria	0.000524	0.00659	CbGeAlD
Regorafenib—CYP2B6—blood plasma—malaria	0.00052	0.00654	CbGeAlD
Regorafenib—TEK—blood—malaria	0.000519	0.00653	CbGeAlD
Regorafenib—ABL1—saliva-secreting gland—malaria	0.000518	0.00651	CbGeAlD
Regorafenib—CYP2C9—blood plasma—malaria	0.000515	0.00648	CbGeAlD
Regorafenib—Gastrointestinal pain—Proguanil—malaria	0.000514	0.00652	CcSEcCtD
Regorafenib—Vomiting—Pyrimethamine—malaria	0.000513	0.00651	CcSEcCtD
Regorafenib—UGT1A9—liver—malaria	0.000512	0.00644	CbGeAlD
Regorafenib—Neutropenia—Clindamycin—malaria	0.000511	0.00649	CcSEcCtD
Regorafenib—FLT4—liver—malaria	0.000505	0.00635	CbGeAlD
Regorafenib—Toxic epidermal necrolysis—Quinidine barbiturate—malaria	0.000504	0.0064	CcSEcCtD
Regorafenib—FLT1—blood—malaria	0.000502	0.00632	CbGeAlD
Regorafenib—Neutropenia—Quinine—malaria	0.000501	0.00636	CcSEcCtD
Regorafenib—Neutropenia—Quinidine—malaria	0.000501	0.00636	CcSEcCtD
Regorafenib—RAF1—blood—malaria	0.000499	0.00628	CbGeAlD
Regorafenib—FGFR1—liver—malaria	0.000498	0.00627	CbGeAlD
Regorafenib—Abdominal pain—Proguanil—malaria	0.000497	0.00631	CcSEcCtD
Regorafenib—Body temperature increased—Proguanil—malaria	0.000497	0.00631	CcSEcCtD
Regorafenib—ABL1—hematopoietic system—malaria	0.000494	0.00622	CbGeAlD
Regorafenib—PDGFRA—digestive system—malaria	0.000494	0.00621	CbGeAlD
Regorafenib—RAF1—bone marrow—malaria	0.000483	0.00608	CbGeAlD
Regorafenib—Stevens-Johnson syndrome—Clindamycin—malaria	0.000483	0.00613	CcSEcCtD
Regorafenib—Stevens-Johnson syndrome—Quinidine—malaria	0.000474	0.00601	CcSEcCtD
Regorafenib—Stevens-Johnson syndrome—Quinine—malaria	0.000474	0.00601	CcSEcCtD
Regorafenib—UGT1A1—digestive system—malaria	0.000471	0.00593	CbGeAlD
Regorafenib—PDGFRA—blood—malaria	0.000471	0.00592	CbGeAlD
Regorafenib—KIT—kidney—malaria	0.000465	0.00585	CbGeAlD
Regorafenib—BRAF—brain—malaria	0.000465	0.00585	CbGeAlD
Regorafenib—Leukopenia—Sulfadiazine—malaria	0.000458	0.00581	CcSEcCtD
Regorafenib—PDGFRB—kidney—malaria	0.000455	0.00572	CbGeAlD
Regorafenib—Neutropenia—Quinidine barbiturate—malaria	0.000452	0.00574	CcSEcCtD
Regorafenib—UGT1A1—blood—malaria	0.000449	0.00565	CbGeAlD
Regorafenib—KDR—digestive system—malaria	0.000446	0.0056	CbGeAlD
Regorafenib—EPHX2—brain—malaria	0.000444	0.00559	CbGeAlD
Regorafenib—Haemoglobin—Quinidine—malaria	0.000431	0.00547	CcSEcCtD
Regorafenib—Haemoglobin—Quinine—malaria	0.000431	0.00547	CcSEcCtD
Regorafenib—Infestation—Pentoxifylline—malaria	0.000431	0.00546	CcSEcCtD
Regorafenib—Infestation NOS—Pentoxifylline—malaria	0.000431	0.00546	CcSEcCtD
Regorafenib—Diarrhoea—Proguanil—malaria	0.00043	0.00546	CcSEcCtD
Regorafenib—Haemorrhage—Quinine—malaria	0.000429	0.00545	CcSEcCtD
Regorafenib—Haemorrhage—Quinidine—malaria	0.000429	0.00545	CcSEcCtD
Regorafenib—Stevens-Johnson syndrome—Quinidine barbiturate—malaria	0.000428	0.00543	CcSEcCtD
Regorafenib—KDR—blood—malaria	0.000425	0.00534	CbGeAlD
Regorafenib—Urinary tract disorder—Quinine—malaria	0.000424	0.00538	CcSEcCtD
Regorafenib—Urinary tract disorder—Quinidine—malaria	0.000424	0.00538	CcSEcCtD
Regorafenib—FGFR2—liver—malaria	0.000424	0.00533	CbGeAlD
Regorafenib—Urethral disorder—Quinine—malaria	0.000421	0.00534	CcSEcCtD
Regorafenib—Urethral disorder—Quinidine—malaria	0.000421	0.00534	CcSEcCtD
Regorafenib—EPHA2—liver—malaria	0.000416	0.00524	CbGeAlD
Regorafenib—Erythema multiforme—Clindamycin—malaria	0.000414	0.00525	CcSEcCtD
Regorafenib—KDR—bone marrow—malaria	0.000411	0.00517	CbGeAlD
Regorafenib—Thrombocytopenia—Sulfadiazine—malaria	0.000409	0.00519	CcSEcCtD
Regorafenib—Hepatobiliary disease—Pentoxifylline—malaria	0.000407	0.00517	CcSEcCtD
Regorafenib—TEK—liver—malaria	0.000406	0.00511	CbGeAlD
Regorafenib—Erythema multiforme—Quinidine—malaria	0.000406	0.00515	CcSEcCtD
Regorafenib—Erythema multiforme—Quinine—malaria	0.000406	0.00515	CcSEcCtD
Regorafenib—ABL1—kidney—malaria	0.000405	0.0051	CbGeAlD
Regorafenib—FLT4—brain—malaria	0.000401	0.00504	CbGeAlD
Regorafenib—Vomiting—Proguanil—malaria	0.0004	0.00507	CcSEcCtD
Regorafenib—Cardiac disorder—Quinine—malaria	0.000398	0.00505	CcSEcCtD
Regorafenib—Cardiac disorder—Quinidine—malaria	0.000398	0.00505	CcSEcCtD
Regorafenib—Rash—Proguanil—malaria	0.000396	0.00503	CcSEcCtD
Regorafenib—Dermatitis—Proguanil—malaria	0.000396	0.00503	CcSEcCtD
Regorafenib—FGFR1—brain—malaria	0.000395	0.00497	CbGeAlD
Regorafenib—KIT—digestive system—malaria	0.000395	0.00497	CbGeAlD
Regorafenib—Headache—Proguanil—malaria	0.000394	0.005	CcSEcCtD
Regorafenib—CYP3A4—blood plasma—malaria	0.000393	0.00494	CbGeAlD
Regorafenib—FLT1—liver—malaria	0.000393	0.00494	CbGeAlD
Regorafenib—RAF1—liver—malaria	0.00039	0.00491	CbGeAlD
Regorafenib—Haemoglobin—Quinidine barbiturate—malaria	0.000389	0.00494	CcSEcCtD
Regorafenib—Haemoglobin—Pentoxifylline—malaria	0.000389	0.00493	CcSEcCtD
Regorafenib—Haemorrhage—Quinidine barbiturate—malaria	0.000387	0.00491	CcSEcCtD
Regorafenib—Mediastinal disorder—Quinidine—malaria	0.000387	0.00491	CcSEcCtD
Regorafenib—Mediastinal disorder—Quinine—malaria	0.000387	0.00491	CcSEcCtD
Regorafenib—Haemorrhage—Pentoxifylline—malaria	0.000387	0.00491	CcSEcCtD
Regorafenib—PDGFRB—digestive system—malaria	0.000386	0.00485	CbGeAlD
Regorafenib—Urinary tract disorder—Quinidine barbiturate—malaria	0.000382	0.00485	CcSEcCtD
Regorafenib—Urethral disorder—Quinidine barbiturate—malaria	0.00038	0.00482	CcSEcCtD
Regorafenib—KIT—blood—malaria	0.000376	0.00473	CbGeAlD
Regorafenib—Malnutrition—Quinidine—malaria	0.000374	0.00474	CcSEcCtD
Regorafenib—Malnutrition—Quinine—malaria	0.000374	0.00474	CcSEcCtD
Regorafenib—Nausea—Proguanil—malaria	0.000373	0.00474	CcSEcCtD
Regorafenib—PDGFRA—liver—malaria	0.000368	0.00463	CbGeAlD
Regorafenib—PDGFRB—blood—malaria	0.000367	0.00462	CbGeAlD
Regorafenib—CYP2C19—hematopoietic system—malaria	0.000367	0.00462	CbGeAlD
Regorafenib—Erythema multiforme—Quinidine barbiturate—malaria	0.000366	0.00465	CcSEcCtD
Regorafenib—KIT—bone marrow—malaria	0.000364	0.00458	CbGeAlD
Regorafenib—Decreased appetite—Sulfadiazine—malaria	0.000363	0.0046	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Sulfadiazine—malaria	0.00036	0.00457	CcSEcCtD
Regorafenib—Cardiac disorder—Quinidine barbiturate—malaria	0.000359	0.00456	CcSEcCtD
Regorafenib—PDGFRB—bone marrow—malaria	0.000356	0.00447	CbGeAlD
Regorafenib—RET—brain—malaria	0.000354	0.00445	CbGeAlD
Regorafenib—Anaemia—Clindamycin—malaria	0.000352	0.00447	CcSEcCtD
Regorafenib—UGT1A1—liver—malaria	0.000351	0.00441	CbGeAlD
Regorafenib—Tremor—Quinine—malaria	0.00035	0.00444	CcSEcCtD
Regorafenib—Tremor—Quinidine—malaria	0.00035	0.00444	CcSEcCtD
Regorafenib—Mediastinal disorder—Quinidine barbiturate—malaria	0.000349	0.00443	CcSEcCtD
Regorafenib—ABL1—digestive system—malaria	0.000344	0.00432	CbGeAlD
Regorafenib—Gastrointestinal pain—Sulfadiazine—malaria	0.000341	0.00433	CcSEcCtD
Regorafenib—Leukopenia—Clindamycin—malaria	0.000341	0.00433	CcSEcCtD
Regorafenib—Malnutrition—Quinidine barbiturate—malaria	0.000337	0.00428	CcSEcCtD
Regorafenib—FGFR2—brain—malaria	0.000336	0.00423	CbGeAlD
Regorafenib—Leukopenia—Quinine—malaria	0.000334	0.00424	CcSEcCtD
Regorafenib—Leukopenia—Quinidine—malaria	0.000334	0.00424	CcSEcCtD
Regorafenib—KDR—liver—malaria	0.000332	0.00417	CbGeAlD
Regorafenib—EPHA2—brain—malaria	0.00033	0.00415	CbGeAlD
Regorafenib—Body temperature increased—Sulfadiazine—malaria	0.00033	0.00419	CcSEcCtD
Regorafenib—Abdominal pain—Sulfadiazine—malaria	0.00033	0.00419	CcSEcCtD
Regorafenib—Hypertension—Clindamycin—malaria	0.000329	0.00417	CcSEcCtD
Regorafenib—ABL1—blood—malaria	0.000328	0.00412	CbGeAlD
Regorafenib—ABCG2—saliva-secreting gland—malaria	0.000327	0.00411	CbGeAlD
Regorafenib—TEK—brain—malaria	0.000322	0.00405	CbGeAlD
Regorafenib—CYP2C8—hematopoietic system—malaria	0.000321	0.00403	CbGeAlD
Regorafenib—ABL1—bone marrow—malaria	0.000317	0.00399	CbGeAlD
Regorafenib—Tremor—Quinidine barbiturate—malaria	0.000316	0.00401	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000316	0.00401	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000316	0.00401	CcSEcCtD
Regorafenib—Tremor—Pentoxifylline—malaria	0.000315	0.004	CcSEcCtD
Regorafenib—FLT1—brain—malaria	0.000312	0.00392	CbGeAlD
Regorafenib—Anaemia—Pentoxifylline—malaria	0.000311	0.00395	CcSEcCtD
Regorafenib—RAF1—brain—malaria	0.00031	0.0039	CbGeAlD
Regorafenib—Thrombocytopenia—Clindamycin—malaria	0.000304	0.00386	CcSEcCtD
Regorafenib—Leukopenia—Quinidine barbiturate—malaria	0.000302	0.00383	CcSEcCtD
Regorafenib—Leukopenia—Pentoxifylline—malaria	0.000301	0.00382	CcSEcCtD
Regorafenib—Nervous system disorder—Quinidine—malaria	0.000299	0.00379	CcSEcCtD
Regorafenib—Nervous system disorder—Quinine—malaria	0.000299	0.00379	CcSEcCtD
Regorafenib—Thrombocytopenia—Quinine—malaria	0.000299	0.00379	CcSEcCtD
Regorafenib—Thrombocytopenia—Quinidine—malaria	0.000299	0.00379	CcSEcCtD
Regorafenib—Skin disorder—Quinidine—malaria	0.000296	0.00376	CcSEcCtD
Regorafenib—Skin disorder—Quinine—malaria	0.000296	0.00376	CcSEcCtD
Regorafenib—KIT—liver—malaria	0.000294	0.0037	CbGeAlD
Regorafenib—PDGFRA—brain—malaria	0.000292	0.00367	CbGeAlD
Regorafenib—Hypertension—Pentoxifylline—malaria	0.000291	0.00369	CcSEcCtD
Regorafenib—CYP2B6—hematopoietic system—malaria	0.000288	0.00362	CbGeAlD
Regorafenib—PDGFRB—liver—malaria	0.000287	0.00361	CbGeAlD
Regorafenib—Diarrhoea—Sulfadiazine—malaria	0.000286	0.00362	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000285	0.00362	CcSEcCtD
Regorafenib—CYP2C9—hematopoietic system—malaria	0.000285	0.00358	CbGeAlD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000285	0.00361	CcSEcCtD
Regorafenib—Dry mouth—Pentoxifylline—malaria	0.00028	0.00356	CcSEcCtD
Regorafenib—ABCB1—blood plasma—malaria	0.000278	0.0035	CbGeAlD
Regorafenib—Infection—Pentoxifylline—malaria	0.000273	0.00346	CcSEcCtD
Regorafenib—Nervous system disorder—Quinidine barbiturate—malaria	0.00027	0.00342	CcSEcCtD
Regorafenib—Thrombocytopenia—Quinidine barbiturate—malaria	0.000269	0.00342	CcSEcCtD
Regorafenib—Thrombocytopenia—Pentoxifylline—malaria	0.000269	0.00341	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Clindamycin—malaria	0.000268	0.0034	CcSEcCtD
Regorafenib—Fatigue—Clindamycin—malaria	0.000268	0.0034	CcSEcCtD
Regorafenib—Skin disorder—Quinidine barbiturate—malaria	0.000267	0.00339	CcSEcCtD
Regorafenib—Skin disorder—Pentoxifylline—malaria	0.000267	0.00339	CcSEcCtD
Regorafenib—Pain—Clindamycin—malaria	0.000266	0.00337	CcSEcCtD
Regorafenib—Vomiting—Sulfadiazine—malaria	0.000265	0.00337	CcSEcCtD
Regorafenib—Decreased appetite—Quinine—malaria	0.000265	0.00336	CcSEcCtD
Regorafenib—Decreased appetite—Quinidine—malaria	0.000265	0.00336	CcSEcCtD
Regorafenib—KDR—brain—malaria	0.000263	0.00331	CbGeAlD
Regorafenib—Gastrointestinal disorder—Quinidine—malaria	0.000263	0.00334	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Quinine—malaria	0.000263	0.00334	CcSEcCtD
Regorafenib—Rash—Sulfadiazine—malaria	0.000263	0.00334	CcSEcCtD
Regorafenib—Dermatitis—Sulfadiazine—malaria	0.000263	0.00334	CcSEcCtD
Regorafenib—CYP2C8—kidney—malaria	0.000263	0.0033	CbGeAlD
Regorafenib—Gastrointestinal pain—Dapsone—malaria	0.000263	0.00333	CcSEcCtD
Regorafenib—Headache—Sulfadiazine—malaria	0.000261	0.00332	CcSEcCtD
Regorafenib—ABL1—liver—malaria	0.000256	0.00322	CbGeAlD
Regorafenib—CYP2C19—digestive system—malaria	0.000255	0.00321	CbGeAlD
Regorafenib—Gastrointestinal pain—Clindamycin—malaria	0.000254	0.00322	CcSEcCtD
Regorafenib—Body temperature increased—Dapsone—malaria	0.000254	0.00322	CcSEcCtD
Regorafenib—Abdominal pain—Dapsone—malaria	0.000254	0.00322	CcSEcCtD
Regorafenib—Gastrointestinal pain—Quinine—malaria	0.000249	0.00316	CcSEcCtD
Regorafenib—Gastrointestinal pain—Quinidine—malaria	0.000249	0.00316	CcSEcCtD
Regorafenib—Nausea—Sulfadiazine—malaria	0.000248	0.00315	CcSEcCtD
Regorafenib—Body temperature increased—Clindamycin—malaria	0.000246	0.00312	CcSEcCtD
Regorafenib—Abdominal pain—Clindamycin—malaria	0.000246	0.00312	CcSEcCtD
Regorafenib—CYP2C19—blood—malaria	0.000243	0.00306	CbGeAlD
Regorafenib—Abdominal pain—Quinidine—malaria	0.000241	0.00306	CcSEcCtD
Regorafenib—Body temperature increased—Quinidine—malaria	0.000241	0.00306	CcSEcCtD
Regorafenib—Abdominal pain—Quinine—malaria	0.000241	0.00306	CcSEcCtD
Regorafenib—Body temperature increased—Quinine—malaria	0.000241	0.00306	CcSEcCtD
Regorafenib—Decreased appetite—Quinidine barbiturate—malaria	0.000239	0.00304	CcSEcCtD
Regorafenib—Decreased appetite—Pentoxifylline—malaria	0.000239	0.00303	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000238	0.00301	CcSEcCtD
Regorafenib—CYP2B6—kidney—malaria	0.000236	0.00296	CbGeAlD
Regorafenib—Pain—Quinidine barbiturate—malaria	0.000235	0.00299	CcSEcCtD
Regorafenib—KIT—brain—malaria	0.000233	0.00294	CbGeAlD
Regorafenib—PDGFRB—brain—malaria	0.000228	0.00287	CbGeAlD
Regorafenib—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000225	0.00286	CcSEcCtD
Regorafenib—Gastrointestinal pain—Pentoxifylline—malaria	0.000225	0.00285	CcSEcCtD
Regorafenib—Asthenia—Clindamycin—malaria	0.000223	0.00283	CcSEcCtD
Regorafenib—Asthenia—Quinine—malaria	0.000219	0.00278	CcSEcCtD
Regorafenib—Asthenia—Quinidine—malaria	0.000219	0.00278	CcSEcCtD
Regorafenib—Abdominal pain—Quinidine barbiturate—malaria	0.000218	0.00276	CcSEcCtD
Regorafenib—Body temperature increased—Quinidine barbiturate—malaria	0.000218	0.00276	CcSEcCtD
Regorafenib—CYP3A4—hematopoietic system—malaria	0.000217	0.00273	CbGeAlD
Regorafenib—Abdominal pain—Pentoxifylline—malaria	0.000217	0.00276	CcSEcCtD
Regorafenib—Body temperature increased—Pentoxifylline—malaria	0.000217	0.00276	CcSEcCtD
Regorafenib—Diarrhoea—Clindamycin—malaria	0.000213	0.0027	CcSEcCtD
Regorafenib—CYP2C8—blood—malaria	0.000212	0.00267	CbGeAlD
Regorafenib—Diarrhoea—Quinine—malaria	0.000209	0.00265	CcSEcCtD
Regorafenib—Diarrhoea—Quinidine—malaria	0.000209	0.00265	CcSEcCtD
Regorafenib—ABCG2—blood—malaria	0.000207	0.0026	CbGeAlD
Regorafenib—Vomiting—Dapsone—malaria	0.000204	0.00259	CcSEcCtD
Regorafenib—ABL1—brain—malaria	0.000203	0.00256	CbGeAlD
Regorafenib—Headache—Dapsone—malaria	0.000201	0.00255	CcSEcCtD
Regorafenib—CYP2B6—digestive system—malaria	0.0002	0.00252	CbGeAlD
Regorafenib—ABCG2—bone marrow—malaria	0.0002	0.00251	CbGeAlD
Regorafenib—CYP2C9—digestive system—malaria	0.000198	0.00249	CbGeAlD
Regorafenib—Vomiting—Clindamycin—malaria	0.000198	0.00251	CcSEcCtD
Regorafenib—Asthenia—Quinidine barbiturate—malaria	0.000197	0.00251	CcSEcCtD
Regorafenib—Asthenia—Pentoxifylline—malaria	0.000197	0.0025	CcSEcCtD
Regorafenib—Rash—Clindamycin—malaria	0.000196	0.00249	CcSEcCtD
Regorafenib—Dermatitis—Clindamycin—malaria	0.000196	0.00248	CcSEcCtD
Regorafenib—Headache—Clindamycin—malaria	0.000195	0.00247	CcSEcCtD
Regorafenib—Vomiting—Quinidine—malaria	0.000194	0.00246	CcSEcCtD
Regorafenib—Vomiting—Quinine—malaria	0.000194	0.00246	CcSEcCtD
Regorafenib—Rash—Quinidine—malaria	0.000192	0.00244	CcSEcCtD
Regorafenib—Rash—Quinine—malaria	0.000192	0.00244	CcSEcCtD
Regorafenib—Dermatitis—Quinidine—malaria	0.000192	0.00244	CcSEcCtD
Regorafenib—Dermatitis—Quinine—malaria	0.000192	0.00244	CcSEcCtD
Regorafenib—Headache—Quinine—malaria	0.000191	0.00242	CcSEcCtD
Regorafenib—Headache—Quinidine—malaria	0.000191	0.00242	CcSEcCtD
Regorafenib—Nausea—Dapsone—malaria	0.000191	0.00242	CcSEcCtD
Regorafenib—CYP2B6—blood—malaria	0.000191	0.0024	CbGeAlD
Regorafenib—CYP2C19—liver—malaria	0.00019	0.00239	CbGeAlD
Regorafenib—CYP2C9—blood—malaria	0.000189	0.00237	CbGeAlD
Regorafenib—Diarrhoea—Quinidine barbiturate—malaria	0.000188	0.00239	CcSEcCtD
Regorafenib—Diarrhoea—Pentoxifylline—malaria	0.000188	0.00238	CcSEcCtD
Regorafenib—Nausea—Clindamycin—malaria	0.000185	0.00234	CcSEcCtD
Regorafenib—Nausea—Quinidine—malaria	0.000181	0.0023	CcSEcCtD
Regorafenib—Nausea—Quinine—malaria	0.000181	0.0023	CcSEcCtD
Regorafenib—CYP3A4—kidney—malaria	0.000178	0.00224	CbGeAlD
Regorafenib—Vomiting—Quinidine barbiturate—malaria	0.000175	0.00222	CcSEcCtD
Regorafenib—Vomiting—Pentoxifylline—malaria	0.000175	0.00222	CcSEcCtD
Regorafenib—Rash—Quinidine barbiturate—malaria	0.000173	0.0022	CcSEcCtD
Regorafenib—Dermatitis—Quinidine barbiturate—malaria	0.000173	0.0022	CcSEcCtD
Regorafenib—Rash—Pentoxifylline—malaria	0.000173	0.0022	CcSEcCtD
Regorafenib—Dermatitis—Pentoxifylline—malaria	0.000173	0.0022	CcSEcCtD
Regorafenib—Headache—Quinidine barbiturate—malaria	0.000172	0.00219	CcSEcCtD
Regorafenib—Headache—Pentoxifylline—malaria	0.000172	0.00218	CcSEcCtD
Regorafenib—CYP2C8—liver—malaria	0.000166	0.00209	CbGeAlD
Regorafenib—Nausea—Quinidine barbiturate—malaria	0.000163	0.00207	CcSEcCtD
Regorafenib—Nausea—Pentoxifylline—malaria	0.000163	0.00207	CcSEcCtD
Regorafenib—ABCG2—liver—malaria	0.000162	0.00203	CbGeAlD
Regorafenib—ABCB1—hematopoietic system—malaria	0.000154	0.00193	CbGeAlD
Regorafenib—CYP3A4—digestive system—malaria	0.000151	0.0019	CbGeAlD
Regorafenib—CYP2B6—liver—malaria	0.000149	0.00187	CbGeAlD
Regorafenib—CYP2C9—liver—malaria	0.000148	0.00186	CbGeAlD
Regorafenib—CYP3A4—blood—malaria	0.000144	0.00181	CbGeAlD
Regorafenib—CYP2C8—brain—malaria	0.000132	0.00166	CbGeAlD
Regorafenib—ABCG2—brain—malaria	0.000128	0.00161	CbGeAlD
Regorafenib—ABCB1—kidney—malaria	0.000126	0.00158	CbGeAlD
Regorafenib—CYP2B6—brain—malaria	0.000118	0.00149	CbGeAlD
Regorafenib—CYP3A4—liver—malaria	0.000113	0.00141	CbGeAlD
Regorafenib—ABCB1—digestive system—malaria	0.000107	0.00134	CbGeAlD
Regorafenib—ABCB1—blood—malaria	0.000102	0.00128	CbGeAlD
Regorafenib—ABCB1—bone marrow—malaria	9.86e-05	0.00124	CbGeAlD
Regorafenib—ABCB1—liver—malaria	7.96e-05	0.001	CbGeAlD
Regorafenib—ABCB1—brain—malaria	6.32e-05	0.000795	CbGeAlD
Regorafenib—FGFR2—Signaling by NGF—IL6—malaria	1.5e-05	0.000213	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—malaria	1.49e-05	0.000212	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—DECR1—malaria	1.49e-05	0.000212	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CD8A—malaria	1.49e-05	0.000212	CbGpPWpGaD
Regorafenib—KIT—Adaptive Immune System—CD4—malaria	1.49e-05	0.000211	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CD8A—malaria	1.49e-05	0.000211	CbGpPWpGaD
Regorafenib—KIT—Immune System—CD36—malaria	1.48e-05	0.000211	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—CRP—malaria	1.48e-05	0.000211	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—CD4—malaria	1.47e-05	0.000209	CbGpPWpGaD
Regorafenib—KIT—Signaling by NGF—IL6—malaria	1.47e-05	0.000209	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—CD4—malaria	1.47e-05	0.000208	CbGpPWpGaD
Regorafenib—RAF1—NGF signalling via TRKA from the plasma membrane—IL6—malaria	1.45e-05	0.000206	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—DHFR—malaria	1.44e-05	0.000205	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—DHFR—malaria	1.44e-05	0.000205	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—HLA-B—malaria	1.43e-05	0.000204	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—HLA-B—malaria	1.43e-05	0.000203	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—SCARB1—malaria	1.43e-05	0.000203	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—SCARB1—malaria	1.43e-05	0.000203	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PKLR—malaria	1.42e-05	0.000202	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—TLR4—malaria	1.42e-05	0.000202	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—SLC4A1—malaria	1.42e-05	0.000201	CbGpPWpGaD
Regorafenib—FGFR1—Adaptive Immune System—CD4—malaria	1.41e-05	0.000201	CbGpPWpGaD
Regorafenib—PDGFRA—Adaptive Immune System—CD4—malaria	1.41e-05	0.0002	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CD36—malaria	1.41e-05	0.0002	CbGpPWpGaD
Regorafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	1.4e-05	0.000199	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CD36—malaria	1.4e-05	0.000199	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—IL2—malaria	1.39e-05	0.000198	CbGpPWpGaD
Regorafenib—FGFR1—Signaling by NGF—IL6—malaria	1.39e-05	0.000198	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling by NGF—IL6—malaria	1.39e-05	0.000198	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—SLC4A1—malaria	1.38e-05	0.000197	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—malaria	1.37e-05	0.000195	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—ICAM1—malaria	1.36e-05	0.000194	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL18—malaria	1.36e-05	0.000193	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—CRP—malaria	1.36e-05	0.000193	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CD40LG—malaria	1.35e-05	0.000193	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—HBB—malaria	1.35e-05	0.000192	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CD8A—malaria	1.34e-05	0.00019	CbGpPWpGaD
Regorafenib—KIT—Immune System—CRP—malaria	1.34e-05	0.00019	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—DECR1—malaria	1.33e-05	0.000189	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL18—malaria	1.33e-05	0.000188	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—CD4—malaria	1.32e-05	0.000188	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CD40LG—malaria	1.32e-05	0.000188	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—HPGDS—malaria	1.32e-05	0.000187	CbGpPWpGaD
Regorafenib—ABL1—Hemostasis—IL2—malaria	1.32e-05	0.000187	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CD8A—malaria	1.31e-05	0.000186	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—TLR4—malaria	1.3e-05	0.000185	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—TNF—malaria	1.3e-05	0.000185	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—DECR1—malaria	1.3e-05	0.000185	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—SLC4A1—malaria	1.29e-05	0.000184	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—HLA-B—malaria	1.29e-05	0.000183	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—CD4—malaria	1.29e-05	0.000183	CbGpPWpGaD
Regorafenib—KIT—Immune System—TLR4—malaria	1.28e-05	0.000182	CbGpPWpGaD
Regorafenib—PDGFRB—Adaptive Immune System—CD4—malaria	1.27e-05	0.00018	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CRP—malaria	1.27e-05	0.00018	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—G6PD—malaria	1.27e-05	0.00018	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CRP—malaria	1.26e-05	0.00018	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CD36—malaria	1.26e-05	0.00018	CbGpPWpGaD
Regorafenib—FGFR1—Axon guidance—IL6—malaria	1.26e-05	0.000179	CbGpPWpGaD
Regorafenib—ABL1—Immune System—HLA-B—malaria	1.26e-05	0.000178	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling by NGF—IL6—malaria	1.25e-05	0.000178	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—ICAM1—malaria	1.25e-05	0.000178	CbGpPWpGaD
Regorafenib—BRAF—Disease—NOS2—malaria	1.24e-05	0.000176	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CD36—malaria	1.23e-05	0.000175	CbGpPWpGaD
Regorafenib—KIT—Immune System—ICAM1—malaria	1.23e-05	0.000174	CbGpPWpGaD
Regorafenib—KDR—Developmental Biology—IL6—malaria	1.22e-05	0.000174	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—DHFR—malaria	1.22e-05	0.000174	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—TLR4—malaria	1.22e-05	0.000173	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—DECR1—malaria	1.21e-05	0.000173	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—TLR4—malaria	1.21e-05	0.000172	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL18—malaria	1.21e-05	0.000172	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—SCARB1—malaria	1.21e-05	0.000172	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CD40LG—malaria	1.21e-05	0.000172	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—HBB—malaria	1.21e-05	0.000171	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PKLR—malaria	1.2e-05	0.000171	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—IL2—malaria	1.2e-05	0.000171	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CD8A—malaria	1.19e-05	0.00017	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—CD4—malaria	1.18e-05	0.000167	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—HBB—malaria	1.18e-05	0.000167	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—ICAM1—malaria	1.16e-05	0.000166	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—ICAM1—malaria	1.16e-05	0.000165	CbGpPWpGaD
Regorafenib—RAF1—Immune System—HLA-B—malaria	1.15e-05	0.000163	CbGpPWpGaD
Regorafenib—FGFR2—Disease—NOS2—malaria	1.14e-05	0.000163	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CRP—malaria	1.14e-05	0.000162	CbGpPWpGaD
Regorafenib—RAF1—Cytokine Signaling in Immune system—IL6—malaria	1.14e-05	0.000161	CbGpPWpGaD
Regorafenib—RAF1—Adaptive Immune System—CD4—malaria	1.13e-05	0.000161	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—KDR—malaria	1.13e-05	0.000161	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CD36—malaria	1.13e-05	0.00016	CbGpPWpGaD
Regorafenib—KIT—Disease—NOS2—malaria	1.12e-05	0.00016	CbGpPWpGaD
Regorafenib—RAF1—Signaling by NGF—IL6—malaria	1.12e-05	0.000159	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—TNF—malaria	1.12e-05	0.000159	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CRP—malaria	1.11e-05	0.000158	CbGpPWpGaD
Regorafenib—ABL1—Axon guidance—IL6—malaria	1.1e-05	0.000157	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—HBB—malaria	1.1e-05	0.000156	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—TLR4—malaria	1.09e-05	0.000155	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PKLR—malaria	1.07e-05	0.000153	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—G6PD—malaria	1.07e-05	0.000152	CbGpPWpGaD
Regorafenib—FGFR1—Disease—NOS2—malaria	1.07e-05	0.000152	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—NOS2—malaria	1.06e-05	0.000151	CbGpPWpGaD
Regorafenib—ABL1—Immune System—TLR4—malaria	1.06e-05	0.000151	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—CD36—malaria	1.06e-05	0.00015	CbGpPWpGaD
Regorafenib—MAPK11—Developmental Biology—IL6—malaria	1.05e-05	0.00015	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PKLR—malaria	1.05e-05	0.000149	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—ICAM1—malaria	1.05e-05	0.000149	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—IL2—malaria	1.04e-05	0.000148	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—IFNG—malaria	1.04e-05	0.000147	CbGpPWpGaD
Regorafenib—ABL1—Immune System—ICAM1—malaria	1.02e-05	0.000145	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CRP—malaria	1.02e-05	0.000144	CbGpPWpGaD
Regorafenib—RAF1—Axon guidance—IL6—malaria	1.01e-05	0.000144	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—DHODH—malaria	1e-05	0.000142	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—CD4—malaria	1e-05	0.000142	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PKLR—malaria	9.79e-06	0.000139	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—TNF—malaria	9.77e-06	0.000139	CbGpPWpGaD
Regorafenib—RAF1—Immune System—TLR4—malaria	9.73e-06	0.000138	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—HPGDS—malaria	9.66e-06	0.000137	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—NOS2—malaria	9.59e-06	0.000136	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—G6PD—malaria	9.57e-06	0.000136	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—IFNG—malaria	9.51e-06	0.000135	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—CD36—malaria	9.45e-06	0.000134	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—G6PD—malaria	9.34e-06	0.000133	CbGpPWpGaD
Regorafenib—KIT—Immune System—IFNG—malaria	9.34e-06	0.000133	CbGpPWpGaD
Regorafenib—RAF1—Immune System—ICAM1—malaria	9.33e-06	0.000133	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—IL6—malaria	9.29e-06	0.000132	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—IL1B—malaria	9.24e-06	0.000131	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—IL2—malaria	9.2e-06	0.000131	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—CD4—malaria	9.19e-06	0.000131	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—KDR—malaria	9.18e-06	0.000131	CbGpPWpGaD
Regorafenib—BRAF—Disease—CD4—malaria	9.15e-06	0.00013	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—KDR—malaria	9.09e-06	0.000129	CbGpPWpGaD
Regorafenib—KIT—Immune System—CD4—malaria	9.02e-06	0.000128	CbGpPWpGaD
Regorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	9.01e-06	0.000128	CbGpPWpGaD
Regorafenib—FGFR1—Developmental Biology—IL6—malaria	9e-06	0.000128	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—DHFR—malaria	8.96e-06	0.000127	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—CD36—malaria	8.95e-06	0.000127	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—CD36—malaria	8.95e-06	0.000127	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—TNF—malaria	8.93e-06	0.000127	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—SCARB1—malaria	8.87e-06	0.000126	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IFNG—malaria	8.86e-06	0.000126	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IFNG—malaria	8.84e-06	0.000126	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—G6PD—malaria	8.73e-06	0.000124	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—CD36—malaria	8.61e-06	0.000122	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CD4—malaria	8.56e-06	0.000122	CbGpPWpGaD
Regorafenib—RAF1—Disease—NOS2—malaria	8.55e-06	0.000121	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CD4—malaria	8.54e-06	0.000121	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—IL6—malaria	8.53e-06	0.000121	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—SLC4A1—malaria	8.52e-06	0.000121	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—IL1B—malaria	8.48e-06	0.000121	CbGpPWpGaD
Regorafenib—FGFR2—Disease—CD4—malaria	8.48e-06	0.000121	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—IL2—malaria	8.45e-06	0.00012	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—KDR—malaria	8.43e-06	0.00012	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—IL6—malaria	8.38e-06	0.000119	CbGpPWpGaD
Regorafenib—KIT—Immune System—IL1B—malaria	8.33e-06	0.000118	CbGpPWpGaD
Regorafenib—KIT—Disease—CD4—malaria	8.33e-06	0.000118	CbGpPWpGaD
Regorafenib—KIT—Immune System—IL2—malaria	8.3e-06	0.000118	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—KDR—malaria	8.28e-06	0.000118	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—IL6—malaria	8.19e-06	0.000116	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—HPGDS—malaria	8.18e-06	0.000116	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—DECR1—malaria	8.01e-06	0.000114	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IFNG—malaria	7.97e-06	0.000113	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—IL6—malaria	7.95e-06	0.000113	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—IL6—malaria	7.93e-06	0.000113	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IL1B—malaria	7.91e-06	0.000112	CbGpPWpGaD
Regorafenib—FGFR1—Disease—CD4—malaria	7.9e-06	0.000112	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IL1B—malaria	7.89e-06	0.000112	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—CD4—malaria	7.88e-06	0.000112	CbGpPWpGaD
Regorafenib—ABL1—Developmental Biology—IL6—malaria	7.88e-06	0.000112	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IL2—malaria	7.88e-06	0.000112	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IL2—malaria	7.86e-06	0.000112	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—KDR—malaria	7.86e-06	0.000112	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—KDR—malaria	7.84e-06	0.000111	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IFNG—malaria	7.76e-06	0.00011	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CD4—malaria	7.69e-06	0.000109	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—CD36—malaria	7.59e-06	0.000108	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—DHFR—malaria	7.59e-06	0.000108	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—SCARB1—malaria	7.51e-06	0.000107	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CD4—malaria	7.5e-06	0.000107	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—IL2—malaria	7.32e-06	0.000104	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—HPGDS—malaria	7.3e-06	0.000104	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—HBB—malaria	7.25e-06	0.000103	CbGpPWpGaD
Regorafenib—RAF1—Developmental Biology—IL6—malaria	7.21e-06	0.000102	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—IL6—malaria	7.14e-06	0.000102	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—HPGDS—malaria	7.13e-06	0.000101	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL1B—malaria	7.1e-06	0.000101	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—CD4—malaria	7.1e-06	0.000101	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IFNG—malaria	7.1e-06	0.000101	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL2—malaria	7.08e-06	0.000101	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—KDR—malaria	7.06e-06	0.0001	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—IL6—malaria	6.96e-06	9.9e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL1B—malaria	6.92e-06	9.84e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—IL2—malaria	6.92e-06	9.84e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—IL2—malaria	6.9e-06	9.82e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL2—malaria	6.9e-06	9.81e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CD4—malaria	6.86e-06	9.75e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—DHFR—malaria	6.77e-06	9.63e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—SCARB1—malaria	6.7e-06	9.53e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—HPGDS—malaria	6.66e-06	9.46e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—DHFR—malaria	6.61e-06	9.4e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—SCARB1—malaria	6.54e-06	9.3e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PKLR—malaria	6.46e-06	9.18e-05	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—IL6—malaria	6.37e-06	9.05e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL1B—malaria	6.33e-06	9e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—CD4—malaria	6.33e-06	9e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL2—malaria	6.31e-06	8.97e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—KDR—malaria	6.29e-06	8.94e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—DHFR—malaria	6.18e-06	8.78e-05	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—IL6—malaria	6.11e-06	8.69e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—SCARB1—malaria	6.11e-06	8.69e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—IL2—malaria	5.95e-06	8.46e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—IL2—malaria	5.9e-06	8.38e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—G6PD—malaria	5.76e-06	8.18e-05	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—CD36—malaria	5.57e-06	7.91e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—IL2—malaria	5.46e-06	7.77e-05	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—IL6—malaria	5.41e-06	7.69e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IL2—malaria	5.37e-06	7.63e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IL2—malaria	5.09e-06	7.24e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IL2—malaria	5.08e-06	7.22e-05	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—IL6—malaria	4.97e-06	7.06e-05	CbGpPWpGaD
Regorafenib—BRAF—Disease—IL6—malaria	4.95e-06	7.03e-05	CbGpPWpGaD
Regorafenib—KIT—Immune System—IL6—malaria	4.88e-06	6.94e-05	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—CD36—malaria	4.71e-06	6.7e-05	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IL6—malaria	4.63e-06	6.58e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IL6—malaria	4.62e-06	6.56e-05	CbGpPWpGaD
Regorafenib—FGFR2—Disease—IL6—malaria	4.59e-06	6.52e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL2—malaria	4.58e-06	6.51e-05	CbGpPWpGaD
Regorafenib—KIT—Disease—IL6—malaria	4.5e-06	6.4e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—HPGDS—malaria	4.39e-06	6.24e-05	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—IL6—malaria	4.3e-06	6.12e-05	CbGpPWpGaD
Regorafenib—FGFR1—Disease—IL6—malaria	4.27e-06	6.08e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—IL6—malaria	4.26e-06	6.06e-05	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—CD36—malaria	4.21e-06	5.98e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL6—malaria	4.16e-06	5.91e-05	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—CD36—malaria	4.11e-06	5.84e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL2—malaria	4.08e-06	5.8e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—DHFR—malaria	4.07e-06	5.79e-05	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—IL6—malaria	4.07e-06	5.78e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—IL6—malaria	4.06e-06	5.77e-05	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL6—malaria	4.05e-06	5.76e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—SCARB1—malaria	4.03e-06	5.73e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—IL6—malaria	3.84e-06	5.46e-05	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—CD36—malaria	3.84e-06	5.45e-05	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL6—malaria	3.71e-06	5.27e-05	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—IL6—malaria	3.5e-06	4.97e-05	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—IL6—malaria	3.47e-06	4.93e-05	CbGpPWpGaD
Regorafenib—RAF1—Disease—IL6—malaria	3.42e-06	4.87e-05	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—IL6—malaria	3.21e-06	4.57e-05	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—IL6—malaria	3.15e-06	4.48e-05	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—IL6—malaria	2.99e-06	4.26e-05	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—IL6—malaria	2.99e-06	4.24e-05	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—IL6—malaria	2.69e-06	3.82e-05	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—CD36—malaria	2.53e-06	3.6e-05	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—IL6—malaria	2.4e-06	3.41e-05	CbGpPWpGaD
